ACCREDITATION INFO

Practical Recommendations in Immuno & Molecular Oncology (PRIMO)
April 8-11, 2026 – Ritz Carlton, Maui

Jointly provided by Partners for Advancing Clinical Education and PRIMO Education.

Target Audience

This activity is intended for physicians, physician assistant/physician associates, registered nurses, and other healthcare professions who care for patients with lung, gastrointestinal, genitourinary, gynecologic, breast, and hematologic cancers.

Educational Objectives

Upon completion of this activity, participants should be able to:

  • Apply current evidence and guideline/label recommendations to select and sequence immunotherapy, targeted agents, and ADCs across major tumor types (lung, GI, GU, gynecologic, breast, hematologic).
  • Interpret NGS and tumor-agnostic biomarker results and decide when histology-agnostic approvals should guide treatment versus disease-specific standards or clinical trials.
  • Identify, grade, and initiate management of class-specific toxicities for IO, targeted agents, and ADCs within multidisciplinary workflows demonstrated in tumor boards.
  • Conduct concise, patient-centered counseling on sexual health, survivorship, and treatment expectations, and incorporate digital health/wearables data to support symptom monitoring and timely escalation of care.

Faculty

  • Hope S. Rugo, MD, FASCO
  • Rachna T Shroff, MD, MS, FASCO
  • Don S. Dizon, MD, FACP, FASCO
  • Shane Y. Morita, MD, MS, PhD, FACS

Disclosure of Conflicts of Interest

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies.

Program Agenda

Include agenda with registration and break times listed.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact Stacie Coates prior to the live event at support@primomeeting.org.

Fee Information

Any questions regarding fees or payment please contact Stacie Coates prior to the live event at scoates@primomeeting.org.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and PRIMO Education. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

Partners designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 13.25 contact hours.

PA Continuing Medical Education

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 13.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

This activity has been approved for AMA PRA Category 1 Credit™ by Partners for Advancing Clinical Education.

CME Accredited: Maximum of 13.25 AMA PRA Category 1 Credits™